RESTRUX

Corelink, LLC

Application Filed: 2020-11-10

Trademark Application Details

Mark For: RESTRUX® trademark registration is intended to cover the categories of human cadaveric bone tissue for use in applications in a patient; human cadaveric tissue and bone tissue, cleaned and processed to remove cellular elements, for implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human tissue used to stimulate new bone formation in spine, orthopedic, and trauma surgical applications, all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy.

Status

2020-11-13 UTC

LIVE APPLICATION Awaiting Examination

The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.

Research	OneLook Acronym Finder
Serial Number	90309240
Registration Number	6609723
Mark Literal Elements	RESTRUX
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	Trademark
Current Location	NEW APPLICATION PROCESSING 2020-11-13
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	005: Adhesives 006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Matthew J. Himich
Attorney Docket Number	48439-204675

Timeline

2020-11-10	Application Filed
2020-11-13	Location: NEW APPLICATION PROCESSING
2020-11-13	Status: Live/Pending
2020-11-13	Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
2020-11-13	Transaction Date
2022-01-04	Trademark Registered

Trademark Parties (Applicants & Owners)

Party:	Corelink, LLC
Address	2072 Fenton Logistics Park St. Louis, MISSOURI UNITED STATES 63026
Legal Entity Type	Limited Liability Company
Legal Entity State	MISSOURI

Documents

Application	MULTI	2020-11-10
Drawing	JPEG	2020-11-10

Attorney of Record

MATTHEW J. HIMICH
THOMPSON COBURN LLP
ONE US BANK PLAZA
ST. LOUIS, MO 63101

Good, Services, and Codes

International Codes:	5
U.S. Codes:	005,006,018,044,046,051,052

Type Code	Type
GS0051	Human cadaveric bone tissue for use in applications in a patient; human cadaveric tissue and bone tissue, cleaned and processed to remove cellular elements, for implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human tissue used to stimulate new bone formation in spine, orthopedic, and trauma surgical applications, all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy
GS0051	Human cadaveric bone tissue intended for subsequent implantation in a patient; human cadaveric bone tissue, cleaned and processed to remove cellular elements, intended for subsequent implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human allograft tissue used to stimulate new bone formation in spine, orthopedic, and trauma surgical applications; all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy

Type Code

Type

GS0051

Human cadaveric bone tissue for use in applications in a patient; human cadaveric tissue and bone tissue, cleaned and processed to remove cellular elements, for implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human tissue used to stimulate new bone formation in spine, orthopedic, and trauma surgical applications, all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy

GS0051

Human cadaveric bone tissue intended for subsequent implantation in a patient; human cadaveric bone tissue, cleaned and processed to remove cellular elements, intended for subsequent implantation into a patient to correct a defect or injury; cadaveric tissue grafts in the nature of processed cadaveric bone grafts; human allograft tissue used to stimulate new bone formation in spine, orthopedic, and trauma surgical applications; all of the foregoing excluding intravenous immunoglobulins for use in treatment of immunodeficiency disorders and in immune replacement therapy

Trademark Filing History

Description	Date	Proceeding Number
NEW APPLICATION ENTERED IN TRAM	2020-11-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.